New publication about Shared decision-making

This realist synthesis explores shared decision-making (SDM) to:

(a) provide insights into why prescribing continues in end-of-life care;

(b) build a conceptual platform for optimizing ATT prescribing for persons living with cancer towards end-of-life.

Conclusion
Implementation of ATT deprescribing is enabled or constrained by
(a) the meaning of medications to patients;
(b) clinician engagement and understanding;
(c) multi-disciplinary clinical decision-making processes (including support tools);
(d) patient empowerment;
(e) organizational investment.

Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis